Hepatitis C among drug users in Europe. Epidemiology, treatment and prevention
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Ētahi atu kaituhi: | |
| Hōputu: | Monograph |
| Reo: | Ingarihi |
| I whakaputaina: |
Lisboa
European Monitoring Centre for Drugs and Drug Addiction
2016
|
| Rangatū: | Insights
23 |
| Ngā marau: | |
| Urunga tuihono: | Servidor Enlace web |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite: Hepatitis C among drug users in Europe. Epidemiology, treatment and prevention
- Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
- Increasing access to hepatitis C testing and care for people who inject drugs. Identifying barriers to and opportunities for supporting hepatitis C testing and care in drug services: a participatory diagnostic process
- Evidence for the effectiveness of interventions to prevent infections: Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour among people who inject drugs
- Eliminating Hepatitis C in Europe: A report on policy implementation for people who inject drugs
- Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe
- Plan Estratégico para el Abordaje de la Hepatitis C en el Sistema Nacional de Salud